Format

Send to

Choose Destination
Drug Discov Today. 2016 Dec;21(12):1863-1868. doi: 10.1016/j.drudis.2016.07.002. Epub 2016 Jul 12.

What will the crowd fund? Preferences of prospective donors for drug development fundraising campaigns.

Author information

1
Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6 T 1Z3, Canada.
2
Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, 2405 Wesbrook Mall, Vancouver, BC V6 T 1Z3, Canada; Centre for Health Evaluation and Outcomes Sciences, Providence Health Research Institute, 588 - 1081 Burrard Street, St Paul's Hospital, Vancouver, BC V6Z 1Y6, Canada. Electronic address: larry.lynd@ubc.ca.

Abstract

Biomedical researchers are increasingly turning to project-based online fundraising (i.e., crowdfunding) as a complementary source of research funding. To help inform the fundraising strategies adopted by researchers who take this approach, we conducted an online survey of prospective donors in North America. Respondents indicated not only an overwhelming preference for donating to projects conducted by nonprofit research organizations, but also an openness to donating to companies that have a 'for-benefit' corporate structure. They also showed a strong preference for projects that have alternate sources of funding, that have the potential to yield a curative therapy, and that focus on common and pediatric diseases.

PMID:
27422268
DOI:
10.1016/j.drudis.2016.07.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center